Statistics
Publications
11
Citations
354
H-Index
10
Active since
2004
Affiliations
Y Dündar is an author at University of Liverpool specializing in medicine, clinical evidence review, and chemotherapy.
Publications per year
2004–2016
11
11
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin’s lymphoma
Y Dündar, A Bagust, Juliet Hounsome et al. · Health Technology Assessment · 2009 · 43 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Erlotinib for the treatment of relapsed non-small cell lung cancer
C McLeod, A Bagust, Angela Boland et al. · Health Technology Assessment · 2009 · 39 citations · Full text
Medicine, Oncology, Pharmacology +14
A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
Gurpreet Ghattaoraya, Y Dündar, Faviel F. González-Galarza et al. · Database · 2016 · 34 citations · Full text
1–5 of 11